ClinicalTrials.gg
RecruitingNCT03885349IMP-ADAPsUpdated Dec 6, 2023

Motivational Strategies in Batterer Intervention Programs for Offenders With Alcohol/Drug Abuse Problems (IMP-ADAPs)

An interventional study of SBIP+ ADAPs-IMP and SBIP+IMP in Intimate Partner Violence Against Women, Alcohol Abuse and Drug Abuse, sponsored by University of Valencia. Recruiting at 1 site in Spain. Open to male participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-12-06.

Sponsored by University of Valencia · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Nov 2025, 11 months ago, but the record still lists the study as recruiting.
  • Started Mar 2019; still recruiting 7 years 8 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
18 Years and older
Sex
Male
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 25 studies in Alcoholism with a site in Spain — 7 open to participants now, 7 under way, 1 of them phase 3. Alcoholism · Spain.

Planned enrollment
15th of 20
80 · median 118
Started
2019
with 2 others
No phase
15 of 25
5 open now
Registered
12th of 25
by date

Among the 25 studies in Alcoholism with a site in Spain, this one is the 15th largest by planned enrollment of the 20 interventional ones that give a count, is one of 3 that started in 2019, is one of 15 with no phase, and was the 12th registered.

Alcoholism

1,679 studies on the registry are indexed under Alcoholism; 333 are open to participants now.

Browse Alcoholism studies →

Open to participants now

7 of the 25 studies in Alcoholism with a site in Spain are open now. Recruiting first, the newest first:

1 more — sign in →

All 7 open studies →

A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →

Who these studies take

Of the 238 Alcoholism studies recruiting now, 85 (36%) set no upper age limit and 131 (55%) stop at 75 or younger; 9 take children under 18; 64 take healthy volunteers.

This study: 18 Years and older · male · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 25 studies in Alcoholism with a site in Spain, or all of them as a file.
02

Study summary

Alcohol and/or drug abuse problems (ADAPs) have been consistently identified in the scientific literature as a risk factor of intimate partner violence against women (IPVAW). Around 50% of IPVAW offenders referred to batterer intervention programs (BIPs) have ADAPs. ADAPs are also one of the main predictors of BIPs dropout. In Spain, the majority of BIPs do not fit the intervention to specific needs or characteristics of IPVAW offenders, such as those with ADAPs. The aim of this research is to assess the effectiveness of a new motivational strategy adapted to IPVAW offenders with ADAPs, aiming to increase treatment adherence and to improve BIPs outcomes. The motivational strategy will include an individualized motivational plan (IMP) developed for each participant with ADAPs (IMP-ADAPs). In these IMPs one of the main aims will be to reduce alcohol and/or drug consumption. The current study will use a randomized control trial. Participants with ADAPs will be allocated to one of two treatment conditions: experimental condition: Standard batterer intervention program (SBIP) plus individualized motivational plan focused in ADAPs (SBIP+ ADAPs-IMP), and control condition: Standard batterer intervention program plus individualized motivational plan (SBIP+IMP). Primary/final outcomes will be recidivism and ADAPs reduction. Secondary/proximal outcomes will include treatment adherence related variables, violence related attitudes and attributions, self-control and psychological adjustment. Outcome variables will be assessed at baseline, at the end of the intervention, and at six months after the intervention will be finished.

03

Conditions studied

  • Intimate Partner Violence Against Women
  • Alcohol Abuse
  • Drug Abuse

Keywords

  • Intimate partner violence
  • Alcohol
  • Drug
  • Batterer intervention programs
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Male
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Males convicted of IPV against their partner or ex-partner
  • Alcohol and/or drugs abuse problems

Exclusion criteria

Exclusion Criteria:

  • No current severe psychological disorders
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Care provider)
Enrollment
80 participants (estimated)

Study arms

  • Experimental
    SBIP+ ADAPs-IMP

    Experimental condition: Standard batterer intervention program (SBIP) plus individualized motivational plan (IMP) focused in alcohol and/or drugs abuse problems (ADAPs).

    Behavioral: SBIP+ ADAPs-IMP

  • Active comparator
    SBIP+IMP

    Control condition: Standard batterer intervention program plus individualized motivational plan (SBIP+IMP)

    Behavioral: SBIP+IMP

Interventions

  • BehavioralSBIP+ ADAPs-IMP

    Standard batterer intervention program plus Individualized Motivational Plans adapted to alcohol and/or drug abuse problems. The SBIP consist of 70 hr of a cognitive-behavioral intervention including discussion topics such as sexism, sex roles, and gender equality. The intervention phase consisted of six modules in which different intervention techniques were applied (i.e., group dynamics, roleplaying, videos, training in cognitive restructuring, emotion management skills). The IMP included a set of motivational strategies to increase treatment compliance and motivation for change and had four main strategies: (a) five individual motivational interviews, to identify IPV related personal goals and follow up their achievement (in this case, one of the goals has to be related to ADAPs); (b) three group sessions where participants share their goals; (c) therapists follow-up and reinforcement of participants' goals; and (d) use of retention techniques.

  • BehavioralSBIP+IMP

    Standard batterer intervention program plus Individualized Motivational Plans. The SBIP consist of 70 hr of a cognitive-behavioral intervention including discussion topics such as sexism, sex roles, and gender equality. The intervention phase consist of six modules in which different intervention techniques are applied (i.e., group dynamics, roleplaying, videos, training in cognitive restructuring, emotion management skills). The IMP include a set of motivational strategies to increase treatment compliance and motivation for change and has four main strategies: (a) five individual motivational interviews, to identify IPV related personal goals and follow up their achievement; (b) three group sessions where participants share their goals, explain their progress to the group, and receive feedback, support and advice from the group; (c) therapists follow-up and reinforcement of participants' goals; and (d) use of retention techniques.

06

What researchers measure

Primary outcomes

  1. Change in alcohol abuse problems

    Alcohol Use Disorders Identification Test. Saunders, Aasland, Babor, De la Fuente, \& Grant, 1993. Total scale range: 0-20 (Higher values indicate worse outcome).

    Time frame: At baseline, at 12 months (end of intervention), and at 18 months (follow-up)

  2. Change in cannabis abuse problems

    Severity Dependence Scale. Gossop et al., 1995. Total scale range: 0-15 (Higher values indicate worse outcome).

    Time frame: At baseline, at 12 months (end of intervention), and at 18 months (follow-up)

  3. Change in cocaine abuse problems

    Severity Dependence Scale. Gossop et al., 1995. Total scale range: 0-15 (Higher values indicate worse outcome).

    Time frame: At baseline, at 12 months (end of intervention), and at 18 months (follow-up)

  4. Change in self-reported physical intimate partner violence against women

    Self-reported physical violence sub-scale from the Conflict Tacticts Scale. Straus, Hamby, Boney-McCoy y Sugarman, 1996. Total scale range: 0-72 (Higher values indicate worse outcome).

    Time frame: At baseline, at 12 months (end of intervention), and at 18 months (follow-up)

  5. Change in self-reported psychological intimate partner violence against women

    Self-reported psychological violence sub-scale from the Conflict Tacticts Scale. Straus, Hamby, Boney-McCoy y Sugarman, 1996. Total scale range: 0-72 (Higher values indicate worse outcome).

    Time frame: At baseline, at 12 months (end of intervention), and at 18 months (follow-up)

  6. Change in risk of recidivism

    The Spousal Assault Risk Assessment. SARA; Kropp y Hart, 2000. Total scale range: 0-40 (Higher values indicate worse outcome)

    Time frame: At baseline, at 12 months (end of intervention), and at 18 months (follow-up)

  7. Police-reported recidivism

    Ministry of Home Affairs' monitoring system for IPV. This system includes information on further incidents of violence by individuals convicted of IPV and reported by any of the institutions involved in victim protection services. Recidivism will be considered to have occurred when this information appear in the system in the 6 months after completing the intervention.

    Time frame: At 18 months (follow-up)

Secondary outcomes

  1. Therapeutic alliance

    Working Alliance Inventory Shortened Observer-rated version (WAI-O-S; Tichenor \& Hill, 1989). Total scale range: 0-74 (Higher values indicate better outcome)

    Time frame: 4 weeks after the first session of the intervention

  2. Change in motivation

    Based on the transtheoretical model of change (Prochaska and DiClemente, 1982; Prochaska et al., 1992), therapists will rate participants' stage of change (pre-contemplation, contemplation, preparation, action, and maintenance). Total range: 1-5 (Higher values indicate better outcome).

    Time frame: At baseline, at 6 months, and at 12 months (end of intervention)

  3. Change in impulsivity

    Plutchik Impulsivity Scale; Plutchnik y Van Pragg, 1989. Total scale range: 11-44 (Higher values indicate worse outcome)

    Time frame: At baseline and at 12 months (end of intervention)

  4. Change in depressive symptomatology

    Spanish reduced version of the Center for Epidemiology Studies-Depression Scale; Herrero y Gracia, 2007. Total scale range: 7-28 (Higher values indicate worse outcome)

    Time frame: At baseline and at 12 months (end of intervention)

  5. Change in self-esteem

    Rosenberg Self-Esteem Scale. Rosenberg, 1965. Total scale range: 10-40 (Higher values indicate better outcome)

    Time frame: At baseline and at 12 months (end of intervention)

  6. Attributions of Responsibility

    Intimate Partner Violence Responsibility Atribution Scale. Lila, Oliver, Catalá-Miñana, Galiana y Gracia, 2014. Three sub-scales: responsibility attribution to the legal system (sub-scale range: 4-20), responsibility attribution to the victim (sub-scale range: 4-20), and responsibility attribution to the offender personal context (sub-scale range: 4-20). Higher values indicate worse outcome.

    Time frame: At baseline and at 12 months (end of intervention)

  7. Change in perceived severity of intimate partner violence against women

    Severity Perception of Intimate Partner Violence Against Women Scale. Gracia, García y Lila (2011). Total scale range: 8-80 (Higher values indicate better outcome)

    Time frame: At baseline and at 12 months (end of intervention)

  8. Change in acceptability of intimate partner violence against women

    Acceptability of Intimate Partner Violence Against Women Scale. Martín-Fernández, Gracia, Marco, Vargas, Santirso and Lila (2018). Total scale range: 0-40 (Higher values indicate worse outcome)

    Time frame: At baseline and at 12 months (end of intervention)

  9. Change in benevolent sexism

    Ambivalent Sexism Inventory. Glick y Fiske, 1996. Two sub-scales: Benevolent sexism (sub-scale range: 0-55) and Hostile sexism (sub-scale range: 0-55). Higher values indicate worse outcome

    Time frame: At baseline and at 12 months (end of intervention)

07

Study locations

1 of 1 sites recruiting
  • Faculty of Psychology
    Valencia, 46010, Spain
    Recruiting
    • Elena Terreros, PhD · Contact
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2019 (actual). Primary completion is estimated for Nov 2025, 80 months after the start.

Of 472 non-industry interventional studies with no phase under Alcoholism, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 54. This study's planned 80 months is above that.

Counting every sponsor, half of 495 studies reached it within 33 months; a quarter within 17 and three quarters within 52.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 5, 2019
First posted
Mar 21, 2019
StartActual
Mar 4, 2019
Primary completionEst.
Nov 30, 2025
CompletionEst.
Dec 30, 2025
Last update
Dec 6, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 6, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03885349
Collaborators
Ministerio de Sanidad, Servicios Sociales e Igualdad
Responsible party
Sponsor
First posted
Mar 21, 2019
Start date
Mar 4, 2019
Primary completion
Nov 30, 2025 (estimated)
Completion
Dec 30, 2025 (estimated)
Last update
Dec 6, 2023

Study contacts

Elena Terreros, PhD
Contact
elenaterreros@gmail.com
+3463030607983918
Marisol Lila, PhD
principal investigator · University of Valencia

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion